316 related articles for article (PubMed ID: 37373139)
1. Exploring the Potential Role of Circulating microRNAs as Biomarkers for Predicting Clinical Response to Neoadjuvant Therapy in Breast Cancer.
Ruiz-Manriquez LM; Villarreal-Garza C; Benavides-Aguilar JA; Torres-Copado A; Isidoro-Sánchez J; Estrada-Meza C; Arvizu-Espinosa MG; Paul S; Cuevas-Diaz Duran R
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373139
[TBL] [Abstract][Full Text] [Related]
2. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.
Kassem NM; Makar WS; Kassem HA; Talima S; Tarek M; Hesham H; El-Desouky MA
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2749-2755. PubMed ID: 31554373
[TBL] [Abstract][Full Text] [Related]
3. Circulating Small EVs miRNAs as Predictors of Pathological Response to Neo-Adjuvant Therapy in Breast Cancer Patients.
Baldasici O; Balacescu L; Cruceriu D; Roman A; Lisencu C; Fetica B; Visan S; Cismaru A; Jurj A; Barbu-Tudoran L; Pileczki V; Vlase L; Tudoran O; Balacescu O
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293478
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of circulating microRNAs as a novel indicator of clinical response to neoadjuvant chemotherapy in breast cancer.
Zhu W; Liu M; Fan Y; Ma F; Xu N; Xu B
Cancer Med; 2018 Sep; 7(9):4420-4433. PubMed ID: 30099860
[TBL] [Abstract][Full Text] [Related]
5. Emergence of Circulating MicroRNAs in Breast Cancer as Diagnostic and Therapeutic Efficacy Biomarkers.
Aggarwal V; Priyanka K; Tuli HS
Mol Diagn Ther; 2020 Apr; 24(2):153-173. PubMed ID: 32067191
[TBL] [Abstract][Full Text] [Related]
6. De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer.
Wu X; Somlo G; Yu Y; Palomares MR; Li AX; Zhou W; Chow A; Yen Y; Rossi JJ; Gao H; Wang J; Yuan YC; Frankel P; Li S; Ashing-Giwa KT; Sun G; Wang Y; Smith R; Robinson K; Ren X; Wang SE
J Transl Med; 2012 Mar; 10():42. PubMed ID: 22400902
[TBL] [Abstract][Full Text] [Related]
7. Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancer.
Casey MC; Sweeney KJ; Brown JA; Kerin MJ
Int J Cancer; 2016 Jul; 139(1):12-22. PubMed ID: 26756433
[TBL] [Abstract][Full Text] [Related]
8. Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis.
Nguyen THN; Nguyen TTN; Nguyen TTM; Nguyen LHM; Huynh LH; Phan HN; Nguyen HT
Breast Cancer Res Treat; 2022 Nov; 196(1):1-15. PubMed ID: 36085533
[TBL] [Abstract][Full Text] [Related]
9. The Role of Micro-RNAs and Circulating Tumor Markers as Predictors of Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
De Palma FDE; Luglio G; Tropeano FP; Pagano G; D'Armiento M; Kroemer G; Maiuri MC; De Palma GD
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987896
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer.
Davey MG; Abbas R; Kerin EP; Casey MC; McGuire A; Waldron RM; Heneghan HM; Newell J; McDermott AM; Keane MM; Lowery AJ; Miller N; Kerin MJ
Breast Cancer Res Treat; 2023 Nov; 202(1):73-81. PubMed ID: 37540289
[TBL] [Abstract][Full Text] [Related]
11. Assessing the Role of MicroRNAs in Predicting Breast Cancer Recurrence-A Systematic Review.
Bouz Mkabaah L; Davey MG; Lennon JC; Bouz G; Miller N; Kerin MJ
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108278
[TBL] [Abstract][Full Text] [Related]
12. ASSESSMENT OF CIRCULATING miRNA LEVELS IN BREAST CANCER PATIENTS DEPENDING ON CLINICAL CHARACTERISTICS AND CHEMOTHERAPY.
Harashchenko О
Exp Oncol; 2024 Feb; 45(4):451-456. PubMed ID: 38328845
[TBL] [Abstract][Full Text] [Related]
13. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy.
Rodríguez-Martínez A; de Miguel-Pérez D; Ortega FG; García-Puche JL; Robles-Fernández I; Exposito J; Martorell-Marugan J; Carmona-Sáez P; Garrido-Navas MDC; Rolfo C; Ilyine H; Lorente JA; Legueren M; Serrano MJ
Breast Cancer Res; 2019 Feb; 21(1):21. PubMed ID: 30728048
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatic Analysis Divulged Novel Prognostic Circulating MicroRNAs and Their Potential Target Genes in Breast Cancer.
Pourgholamali B; Sohrabi B; Salbi M; Akbari S; Rastan I; Sayaf M; Jalil AT; Kadhim MM; Sheervalilou R; Mehrzad N
Appl Biochem Biotechnol; 2023 Jan; 195(1):283-297. PubMed ID: 36074234
[TBL] [Abstract][Full Text] [Related]
15. Circulating Exosomal microRNAs as Predictive Biomarkers of Neoadjuvant Chemotherapy Response in Breast Cancer.
Todorova VK; Byrum SD; Gies AJ; Haynie C; Smith H; Reyna NS; Makhoul I
Curr Oncol; 2022 Jan; 29(2):613-630. PubMed ID: 35200555
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the Role of Circulating MicroRNAs in Predicting Long-Term Survival Outcomes in Breast Cancer: A Prospective, Multicenter Clinical Trial.
Davey MG; McGuire A; Casey MC; Waldron RM; Paganga M; Holian E; Newell J; Heneghan HM; McDermott AM; Keane MM; Lowery AJ; Miller N; Kerin MJ
J Am Coll Surg; 2023 Feb; 236(2):317-327. PubMed ID: 36648259
[TBL] [Abstract][Full Text] [Related]
17. Graphene Oxide-Based Highly Sensitive Assay of Circulating MicroRNAs for Early Prediction of the Response to Neoadjuvant Chemotherapy in Breast Cancer.
Li Z; Xiao H; Li J; Yang Z; Jiang J; Ji J; Peng C; He Y
Anal Chem; 2022 Nov; 94(46):16254-16264. PubMed ID: 36342865
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNAs as indicators in the prediction of neoadjuvant chemotherapy response in luminal B breast cancer.
Zhang Z; Zhang H; Li C; Xiang Q; Xu L; Liu Q; Pang X; Zhang W; Zhang H; Zhang S; Duan X; Liu Y; Cui Y
Thorac Cancer; 2021 Dec; 12(24):3396-3406. PubMed ID: 34751517
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic significance of circulating miRNAs and metabolite profiling in early prediction of breast cancer in Egyptian women.
El-Toukhy SE; El-Daly SM; Kamel MM; Nabih HK
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5437-5451. PubMed ID: 36459290
[TBL] [Abstract][Full Text] [Related]
20. Addressing the Clinical Feasibility of Adopting Circulating miRNA for Breast Cancer Detection, Monitoring and Management with Artificial Intelligence and Machine Learning Platforms.
Ling L; Aldoghachi AF; Chong ZX; Ho WY; Yeap SK; Chin RJ; Soo EZX; Khor JF; Yong YL; Ling JL; Yan NS; Ong AHK
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
